Trial · NCT07656623
Effects of the Multispecies Probiotic Ecologic Barrier in IBS Patients With Upper GI Symptoms and Anxiety, Depression, or Stress
The aim of this clinical trial is to find out whether Ecologic Barrier is effective in supporting the treatment of irritable bowel syndrome (IBS) in adults. The
- Status
- Recruiting
- Sponsor
- Institute of Gastroenterology and Hepatology, Vietnam
- Study type
- Interventional
- Phase
- No phase
- Enrollment
- 60 participants (planned)
- Start
- Jun 1, 2024
- Primary completion
- Jun 30, 2026
- Conditions
- Irritable Bowel Syndrome With Diarrhea
Summary
The aim of this clinical trial is to find out whether Ecologic Barrier is effective in supporting the treatment of irritable bowel syndrome (IBS) in adults. The main questions that this trial aims to answer are: * Does Ecologic Barrier help improve IBS severity when added to standard IBS treatment? * Does Ecologic Barrier help improve symptoms of anxiety, depression, and stress in patients with IBS? * Does Ecologic Barrier help improve upper gastrointestinal symptoms when added to standard IBS treatment? * What adverse events may occur when using Ecologic Barrier?
Interventions
- Ecologic Barrier Dietary supplement
- Ecologic Barrier Dietary supplement
Locations
1 country: Vietnam.
| Facility | City | Country |
|---|---|---|
| Institute of Gastroenterology and Hepatology | Hanoi, Hanoi | Vietnam |
TreatIBS is an informational site and does not provide medical advice. The research summarized here may not apply to your situation. Talk with a clinician before starting, stopping, or changing any treatment.
Listing only. Eligibility is decided by the study team. TreatIBS is not involved in recruitment.